Fatty liver disease is one of the most common liver diseases in the Middle East and North Africa region, and globally. Unfortunately, there is a lack of awareness regarding this condition. The nomenclature changes for NAFLD (to MAFLD or MASLD) have gained considerable attention in the hepatology community. Here, we present our point of view on this ongoing change and debate.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77, 1335–1347 (2023).
Lazarus, J. V. et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat. Rev. Gastroenterol. Hepatol. 19, 60–78 (2022).
Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J. Hepatol. 73, 202–209 (2020).
Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Ann. Hepatol. 29, 101133 (2024).
Shiha, G. et al. MAFLD 2022: an ELPA/ALPA/EASO-ECPO joint statement on disease stigma. J. Hepatol. 77, 1717–1719 (2022).
Younossi, Z. M. et al. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease. J. Hepatol. 80, 419–430 (2024).
Méndez-Sánchez, N., Pal, S. C., Fassio, E., Díaz-Ferrer, J. & Prado-Robles, J. A. MAFLD: perceived stigma — a single-center Mexican patient survey. Hepatol. Int. 17, 507–508 (2023).
Fouad, Y., Sanai, F., Alboraie, M. & Zheng, M.-H. What the new definition of MASLD left behind: dual etiology with viral hepatitis. Clin. Gastroenterol. Hepatol. https://doi.org/10.1016/j.cgh.2023.11.026 (2023).
Younossi, Z. M. et al. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease. J. Hepatol. https://doi.org/10.1016/j.jhep.2024.01.014 (2024).
Fouad, Y. et al. Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition. J. Hepatol. https://doi.org/10.1016/j.jhep.2024.01.033 (2024).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Fouad, Y., Barakat, S., Hashim, A. et al. Towards unifying fatty liver nomenclature: a voice from the Middle East and North Africa. Nat Rev Gastroenterol Hepatol 21, 297–298 (2024). https://doi.org/10.1038/s41575-024-00918-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-024-00918-z